healthcare research

New Research: Unlocking the secrets of Huntington’s Disease

Huntington’s disease (HD) is a devastating neurological disorder that causes death in neurons – a major component of the brain – and eventually the loss of physical and mental abilities. Currently, there are only very limited treatment options. IBM and CHDI Foundation have published research in the Journal of American Chemical Society1 detailing structural features […]

Continue reading

Publishing in The Lancet’s EBioMedicine: New research in AI pushes frontiers in epileptic seizure prediction

Today, The Lancet’s EBioMedicine journal will publish a study led by scientists from IBM Research-Australia and the University of Melbourne marking important progress in personalized seizure forecasting with AI. The findings, described in a paper titled ‘Epileptic Seizure Prediction using Big Data and Deep Learning: Toward a Mobile System,’ present new results in epileptic seizure […]

Continue reading

Machine learning used to surpass MELD in assessing liver disease

Before joining IBM Research in Cambridge in September 2016, I completed a three-year postdoctoral training program at Massachusetts General Hospital (MGH), working closely with Harvard faculty. Now, a collaboration between MGH and IBM Research has yielded a satisfying result – our manuscript, “The MELD-Plus: A Generalizable Prediction Risk Score in Cirrhosis,” was published in PLOS […]

Continue reading

Two IBM Researchers to Speak at TEDGlobal 2017 in Africa

This week in Arusha, Tanzania, hundreds will gather for one of the most highly anticipated events of the year: TEDGlobal. The sold out event brings together entrepreneurs, business leaders,  technologists, dreamers and doers to talk about the challenges and opportunities on the African continent. Representing IBM’s Africa Labs scientists Drs. Abdigani Diriye and David Moinina […]

Continue reading

JDRF and IBM piece together the puzzle of type 1 diabetes

Health-related information is the new frontier of data, and machine learning is one of the most powerful data-analysis tools available. When you put them together, you can glean valuable insights about health and human disease. JDRF and IBM announced today they are collaborating to focus this power on preventing the autoimmune disease type 1 diabetes […]

Continue reading

Healthcare research: IBM uncovers new way to stimulate the body to fight disease

Using nanomaterials to carry drug molecules to specific cells in the body is a relatively new field in healthcare research. But it’s an important one. For example, in order to target therapies to tumors, scientists have developed techniques to attach drug molecules (or vaccines) to nanomaterials like graphene sheets, a single-atom-thick sheet of carbon that […]

Continue reading